Bone Lipogranuloma Mimicking Metastatic Disease on 18F-FDG PET/CT

Selin Kesim1, Fuat Dede1, Emine Cesmecioglu2

  • 1From the Departments of Nuclear Medicine.

Clinical Nuclear Medicine
|September 8, 2023
PubMed

Insights

Primary bone lipogranuloma, a rare condition involving lipid-induced inflammation, can present with high 18F-FDG uptake. This intense uptake on PET/CT scans may mimic metastatic disease, posing a diagnostic challenge in cancer patients.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Pathology

Background:

  • Primary bone lipogranuloma is an exceptionally rare condition.
  • It involves a granulomatous inflammatory response to lipids within bone tissue.
  • The condition's rarity and variable presentation can complicate diagnosis.

Observation:

  • This report details a case of primary bone lipogranuloma in a breast cancer patient.
  • The lesion exhibited significant and intense uptake of 18F-FDG (fluorodeoxyglucose).
  • This high metabolic activity on PET/CT was noted.

Findings:

  • The intense 18F-FDG uptake in the bone lipogranuloma mimicked metastatic breast cancer.
  • This imaging finding posed a diagnostic dilemma, potentially leading to misinterpretation as malignancy.
  • Histopathological examination confirmed the diagnosis of lipogranuloma, distinct from metastatic disease.

Implications:

  • Awareness of primary bone lipogranuloma is crucial for accurate interpretation of 18F-FDG PET/CT scans.
  • This condition highlights the importance of integrating imaging findings with clinical context and, when necessary, biopsy.
  • Distinguishing lipogranuloma from metastatic lesions can prevent unnecessary aggressive treatment and improve patient management.

Related Concept Videos